ANGARA - AI/b2b SaaS/Climate - Non NDA
Overview
🚀 COMPANY: ANGARA Global - a U.K. tech company with offices in Amsterdam and Bahrain.
➡️ THEMES: #B2B SaaS #Artificial Intelligence #Energy #Decarbonization #Revenue-generating #Series A
❇️ HIGHLIGHTS
• Problem: industrial asset inefficiencies result in $100 billion in annual losses plus 1 billion mtCO2 emissions - caused by fouling alone
• Our solution: we built and commercialized an AI-automated digital platform to orchestrate industrial asset efficiency risks to boost clients' margins and reduce CO2.
It is already profitable for us at selected customers and is being deployed company-wide at some of them.
The underlying technology is protected by 40 issued patents ; another 20+ are pending.
• Competitive advantage:
A. Superior prediction accuracy and
B. Forecasting horizon which is 3-7 times greater than that of our competitors
• Customers include Fortune Top 25 companies, e.g. ExxonMobil and TotalEnergies
• Shareholders invested $13 mln. and include:
- Bank of America, Executive Vice Chairman (current) and Global Head, Natural Resources & Energy Transition (ex);
- McKinsey & Company, Global Head for Oil and Gas (ex);
- The White House, Special Adviser to the US President (ex);
- J.P. Morgan, Global Head of Sustainability and Energy (ex);
- F4SE, a VC from Singapore.
• Experienced board and management: NEDs with global experience as top executives of multi-billion dollar companies, including experience as CEO of a $10+ billion public company.
The Founders
- Worked as a team for 6+ years;
- Prior to ANGARA - McKinsey, Morgan Stanley, IBM, IHS, Halliburton.;
- Invested $3.2 mln. in cash in ANGARA;
- A clear vision for a 2-stage $1+ billion EXIT.
• TAM / Total Available Market exceeds $50 billion by 2033
💹 Application Markets: agriculture/food processing, fertilizers, biofuels, oil & gas, petrochemicals, chemicals, power generation, desalination, etc.
🌎 Geography: already used in the EU, Middle East, FSU. Preparing to start sales in the USA and SEA in 2025.
🏆 UNIQUENESS and ADVANTAGE:
Our AI models predict performance with a
(1) higher accuracy and
(2) much farther forecasting horizon of 10-15 months vs. of 2-4 months.
(3) On top of that, our AI automatically generates practical action plans.
👨👩👧👦 TEAM:
Experienced team with prior experience in McKinsey, Morgan Stanley, IBM, IHS, Halliburton.
The founders had successful exits in the US
and worked together for 6+ years.
The Board includes 2 NEDs:
• Panos Cavoulacos (US): Schlumberger, Booz, Hellenic (CEO), McKinsey (ex);
• Jaap Kalkman (Netherlands), Group Chief Investment Officer at ADQ (current), ADL, McKinsey, Roland Berger (ex).
📊 TRACTION:
• $1 mln. in sales in 2023, $5 mln. in the next 12 months.
• Metis Partners (a leading IP expert company) valued our 40 issued patents at $23 mln.
• Customers include Fortune Top 25 companies, e.g. ExxonMobil and TotalEnergies.
• DNV confirmed the technology’s maturity at 8+ TRL; its 400 million tonnes/year CO2 reduction potential and safety.
• ANGARA is part of J.P. Morgan’s Green Economy Banking (and a client of J.P. Morgan).
💰 ROUND: Series A of $5-10 mln.
Use of funds: expand the team
• A. By 10+ people in tech support and deployment function to convert the current $18 mln. pipeline into $4.7 mln. of ARR in the next 12 months;
• B. To build the Frontend for our AI core to convert customers faster;
• C. To launch AI Agents to increase the robustness and versatility of our offering.
Options available: (i) Direct equity OR (ii) Convertible loan @15% p.a. and valuation cap.
✅ EXIT:
The base case EXIT scenario is 2-step:
(1): Interim partial EXIT within 1-2 years as a sale of Fouling Fracturing technology stack.
Potential $100-250 mln.
(2): Ultimate EXIT within 3-4 years as a sale of the business based on DecarbonX AI platform.
Potential $1-2 billion.
Problem and Solution
Cras eleifend purus vitae mattis imperdiet.
Integer fringilla mi ut sem tincidunt, in sagittis odio mollis. Suspendisse a diam lectus. Cras at suscipit risus.
Fusce gravida, ante quis mattis ultricies, lorem neque suscipit ex, semper tincidunt dui mi sit amet elit.
Fusce scelerisque massa sit amet turpis rutrum semper.
Donec ac orci aliquet, tincidunt ligula eu, finibus libero. Pellentesque pharetra consequat congue. Pellentesque quis dolor augue.
Proin non ipsum vel risus rutrum porta. Vivamus sem enim, interdum pretium metus eu, ornare posuere nisl. Duis venenatis accumsan enim, quis blandit lacus posuere at. Sed tincidunt congue blandit. Maecenas interdum quam in mauris condimentum luctus. Donec fermentum egestas risus vel cursus. Ut metus justo, rutrum vel sem ut, consequat laoreet ante. Nunc tincidunt viverra metus, tincidunt viverra elit iaculis sit amet. Integer ullamcorper hendrerit eleifend. Curabitur massa nisi, tempus eget fermentum quis, volutpat non sem. Integer id sagittis dolor. Donec nunc erat, maximus sed magna id, faucibus ultricies velit. Nunc lobortis eget urna at semper.
Donec sollicitudin, tortor ac interdum tempus, mi odio fringilla lacus, sit amet hendrerit mi purus vel nisi. Phasellus nulla ligula, congue quis ullamcorper eget, egestas id leo. Sed et rhoncus libero. Mauris tincidunt ultricies justo ut tincidunt. Nam rhoncus est non erat auctor mattis. Sed quis consectetur ma
Open an account to get
access to more details
Market Opportunity
Cras eleifend purus vitae mattis imperdiet.
Integer fringilla mi ut sem tincidunt, in sagittis odio mollis. Suspendisse a diam lectus. Cras at suscipit risus.
Fusce gravida, ante quis mattis ultricies, lorem neque suscipit ex, semper tincidunt dui mi sit amet elit.
Fusce scelerisque massa sit amet turpis rutrum semper.
Donec ac orci aliquet, tincidunt ligula eu, finibus libero. Pellentesque pharetra consequat congue. Pellentesque quis dolor augue.
Proin non ipsum vel risus rutrum porta. Vivamus sem enim, interdum pretium metus eu, ornare posuere nisl. Duis venenatis accumsan enim, quis blandit lacus posuere at. Sed tincidunt congue blandit. Maecenas interdum quam in mauris condimentum luctus. Donec fermentum egestas risus vel cursus. Ut metus justo, rutrum vel sem ut, consequat laoreet ante. Nunc tincidunt viverra metus, tincidunt viverra elit iaculis sit amet. Integer ullamcorper hendrerit eleifend. Curabitur massa nisi, tempus eget fermentum quis, volutpat non sem. Integer id sagittis dolor. Donec nunc erat, maximus sed magna id, faucibus ultricies velit. Nunc lobortis eget urna at semper.
Donec sollicitudin, tortor ac interdum tempus, mi odio fringilla lacus, sit amet hendrerit mi purus vel nisi. Phasellus nulla ligula, congue quis ullamcorper eget, egestas id leo. Sed et rhoncus libero. Mauris tincidunt ultricies justo ut tincidunt. Nam rhoncus est non erat auc
Open an account to get
access to more details
Sustainable Competitive Advantage & Competition
Ut dignissim eget felis non ultrices. Vivamus fermentum erat at velit varius molestie.
Duis vitae mi neque.
Donec tincidunt, dolor luctus lobortis ultrices, turpis eros cursus turpis, maximus tempor lectus lectus vel diam.
Proin neque lacus, semper vel ex at, eleifend rhoncus est.
Cras non nisi urna. Sed feugiat dignissim erat, eget convallis nisl blandit a. Nullam fringilla diam eget dui placerat fermentum. Maecenas malesuada viverra leo eu bibendum. Nam vulputate enim velit, eu pretium justo tristique ac.
Nam vitae varius augue. Nam pharetra facilisis elementum. Sed nisl risus, vestibulum ut velit at, dapibus sagittis arcu. Nullam sed dolor suscipit, efficitur enim quis, vestibulum sapien. Nunc convallis mauris nec nibh mollis, eget aliquet odio tincidunt.
Phasellus faucibus sem mauris, sed iaculis nisl egestas sed. Sed sit amet gravida elit, sagittis sollicitudin nulla. Vivamus auctor arcu eu scelerisque convallis. Phasellus scelerisque ultrices tincidunt. Curabitur odio libero, faucibus et felis nec, pulvinar facilisis urna. Interdum et malesuada fames ac ante ipsum primis in faucibus. Maecenas ultrices in velit at ultrices.
Pellentesque tempor a risus in elementum. Proin malesuada mauris et mauris bibendum laoreet. Vivamus maximus nulla volutpat, ornare lorem a, vulputate enim.
In dui nisl, vestibulum eu finibus pretium, eleifend et eros. Vivamus in venenatis risus, ut dictum vel
Open an account to get
access to more details
Highlights & Milestones
Cras eleifend purus vitae mattis imperdiet.
Integer fringilla mi ut sem tincidunt, in sagittis odio mollis. Suspendisse a diam lectus. Cras at suscipit risus.
Fusce gravida, ante quis mattis ultricies, lorem neque suscipit ex, semper tincidunt dui mi sit amet elit.
Fusce scelerisque massa sit amet turpis rutrum semper.
Donec ac orci aliquet, tincidunt ligula eu, finibus libero. Pellentesque pharetra consequat congue. Pellentesque quis dolor augue.
Proin non ipsum vel risus rutrum porta. Vivamus sem enim, interdum pretium metus eu, ornare posuere nisl. Duis venenatis accumsan enim, quis blandit lacus posuere at. Sed tincidunt congue blandit. Maecenas interdum quam in mauris condimentum luctus. Donec fermentum egestas risus vel cursus. Ut metus justo, rutrum vel sem ut, consequat laoreet ante. Nunc tincidunt viverra metus, tincidunt viverra elit iaculis sit amet. Integer ullamcorper hendrerit eleifend. Curabitur massa nisi, tempus eget fermentum quis, volutpat non sem. Integer id sagittis dolor. Donec nunc erat, maximus sed magna id, faucibus ultricies velit. Nunc lobortis eget urna at semper.
Donec sollicitudin, tortor ac interdum tempus, mi odio fringilla lacus, sit amet hendrerit mi purus vel nisi. Phasellus nulla ligula, congue quis ullamcorper eget, egestas id leo. Sed et rhoncus libero. Mauris tincidunt ultricies justo ut tincidunt. Nam rhoncus est non erat auctor mattis. Sed quis consectetur ma
Open an account to get
access to more details
See more exiting opportunities on CapitalHQ
BetterX
BetterX offers B2B and B2B2C white-label and API driven software solutions to traditional institutions to offer digital asset services to their clients.
Paycepaid
Paycepaid is a Software as a Service debt collection solution unlike any on the market today with a heavy focus on the debtor. Empowering businesses to manage their end to end collections while providing debtors with a magnitude of options to reduce financial stress and anxiety.
Wholesale Investor
Wholesale Investor, with over 45,000 subscribers, is a leading private capital marketplace operating across Australia, Singapore, and the UK. It has a 15-year track record of connecting private market opportunities with HNW, professional, and family office investors. In just 4 years, our product...
PRIMAL ORGANIX
Primal Organix has created the world’s first botanically derived Terpene blended anti-anxiety health supplement that manages anxiety in minutes. Our purpose is to support positive mental ill-health and well-being in all human beings.
Sustainable Fintech Fund
Startupbootcamp, the #1 Accelerator in the world outside of the US, established in 2010, operates in 27 countries around the globe, has accelerated over 1600+ startups with a success rate of 76% remaining active, raised over $2.2B in total funding, a network of more than 300+ investors, 5000...
Misio
Sustainability performance and stakeholder communications are now fundamental to overall corporate profitability and impact. Misio simplifies a complex eco-system to help large & listed companies shift the sustainability narrative out from annual reports into easy to understand digital...
Pictor
Powering diagnostics with protein signatures. Pictor is transforming health with its patented platform providing accessible, affordable, and scalable diagnostic solutions across the human and animal health verticals. PictArray can detect up to 10 diseases or biomarkers from one small serum, milk,...
National Property Group
National Property Group (NPG) is a trusted alternative provider of property data and insights empowering informed decisions for all property market participants. NPG relaunched its property data & analytics intelligence platform in 2021, delivering instant insights from more than 40 years of...
Novapep
Novapep, an Australian/US biotech, has developed a patented peptide structure called biparediteTM as an oral inflammatory bowel disease therapy, which will be a cost effective first-in-class drug. Biparetide has been shown in animals to be as effective as expensive, injectable biologic drugs (a...
Backed By Leading Investment Groups and Family Offices
